Investigating the Efficacy of Cannabidiol Against Arsenic-Induced Liver Cell Damage
Abstract
Arsenic (As) exposure is known to have harmful effects, prompting the search for effective countermeasures. This study investigated the protective effects of cannabidiol (CBD) against arsenic toxicity in liver cell cultures (THLE-2). The IC50 values for As were determined, finding 10 µM in 2D and 15 µM in 3D cell lines. To assess CBD's protective efficacy, 5 µM of CBD was administered alongside arsenic at its IC50 concentration. The levels of oxidative stress markers, including Glutathione (GSH), malondialdehyde (MDA), myeloperoxidase (MPO), and catalase (CAT), as well as inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6), were measured using ELISA kits. Inductively Coupled Plasma Mass Spectrometry (ICP-MS) analysis was conducted to evaluate As uptake in the cells. The results showed that CBD significantly enhanced cell proliferation and reversed the oxidative stress and inflammatory responses induced by arsenic exposure. Furthermore, CBD effectively reduced arsenic uptake into the cells. These findings provide compelling evidence for CBD's protective role against arsenic-induced toxicity, highlighting its potential as a therapeutic agent in mitigating the harmful effects of arsenic
Keywords
Arsenic, Cannabidiol, Toxicity, THLE-2, ICP-MS
Supporting Institution
Yozgat Bozok University Scientific Research Projects Unit
Project Number
6608-TF/21-475
Ethical Statement
Ethical approval is not required as this is a cell culture study.
Thanks
This study is supported by Yozgat Bozok University Scientific Research Projects Unit (Project number: 6608-TF/21-475).
References
- [1] Ishiguro S., Industries Using Arsenic and Arsenic Compounds, Appl. Organomet. Chem., 6 (4) (1992) 323–331.
- [2] Zhao D., Yi H., Sang N., Arsenic Intake-Induced Gastric Toxicity Is Blocked by Grape Skin Extract by Modulating Inflammation and Oxidative Stress in a Mouse Model, Ecotoxicol. Environ. Saf., 233 (2022) 113305.
- [3] Liu P., Xue Y., Zheng B., Liang Y., Zhang J., Shi J., Chu X., Han X., Chu L. Crocetin Attenuates the Oxidative Stress, Inflammation and Apoptosisin Arsenic Trioxide-Induced Nephrotoxic Rats: Implication of PI3K/AKT Pathway, Int. Immunopharmacol., 88 (2020) 06959.
- [4] Mazumder D.N.G., Haque R., Ghosh N., De B.K., Santra A., Chakraborty D., Smith A.H. Arsenic Levels in Drinking Water and the Prevalence of Skin Lesions in West Bengal, India, Int. J. Epidemiol., 27 (5) (1998) 871–877.
- [5] Abernathy C.O., Liu Y.P., Longfellow D., Aposhian H.V., Beck B., Fowler B., Goyer R., Menzer R., Rossman T., Thompson C., Arsenic: Health Effects, Mechanisms of Actions, and Research Issues, Environ. Health Perspect., 107 (7) (1999) 593–597.
- [6] Santra A., Gupta J., Das De B.K., Roy B., Mazumder D.N.G. Hepatic Manifestations in Chronic Arsenic Toxicity, Indian J. Gastroenterol., 18 (1999) 152–155.
- [7] Nevens F., Staessen D., Sciot R., Van Damme B., Desmet V., Fevery J., De Groote J., Van Steenbergen W. Clinical Aspects of Incomplete Septal Cirrhosis in Comparison with Macronodular Cirrhosis, Gastroenterology, 106 (2) (1994) 459–463.
- [8] Rahman M., Tondel M., Ahmad S.A., Chowdhury I.A., Faruquee M.H., Axelson O. Hypertension and Arsenic Exposure in Bangladesh, Hypertension, 33 (1) (1999) 74–78.
- [9] Benowitz N.L. Cardiotoxicity in the Workplace, Occup. Med., 7 (3) (1992) 465–478.
- [10] Goldsmith S., Arthur H.L., Arsenic-Induced Atypical Ventricular Tachycardia, N. Engl. J. Med., 303 (19) (1980) 1096–1098.